-
Uncategorized4 months agoThis week in Drug Discovery (23 – 27 March)
News round-up for 23 – 27 March February by Bruno Quinney, Content Team at DDW. This week, obesity could be treated in other ways than through drugs suppressing appetite. Elsewhere, prostate cancer...
-
Uncategorized4 months agoBeam reports positive data for genetic disease treatment
Biotechnology company Beam Therapeutics has reported encouraging data for its treatment for the genetic disease Alpha-1 Antitrypsin Deficiency (AATD). Beam announced BEAM-302, a liver-targeting lipid-nanoparticle (LNP) formulation...
-
Uncategorized4 months agoFirst patient dosed in trial of Geographic Atrophy treatment
The first patient has been dosed in a first-in-human clinical trial of a treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). CTx001, developed...
-
Uncategorized4 months agoMHRA to offer early review of non-animal data
The Medicines and Healthcare products Regulatory Agency (MHRA) will offer early review of non-animal data in a decision supporting the government’s strategy to reduce animal testing in...
-
Uncategorized4 months agoSygnature Discovery appoints new Head of In Vivo Pharmacology
CRO Sygnature Discovery has announced the appointment of Susanne Back as Head of In Vivo Pharmacology. Back has 20 years of in vivo pharmacology experience across academia and industry, including...
-
Uncategorized4 months ago
Takeda clears path to FDA with phase 3 data on $4B psoriasis bet
Takeda has posted phase 3 data on an autoimmune asset it acquired for $4 billion, laying down a marker ahead of a fight for market share...
-
Uncategorized4 months agoRadspherin receives patent protection in China
The China National Intellectual Property Administration (CNIPA) has granted a new patent for Radspherin, a radiopharmaceutical treating micrometastases in cancer patients. Radspherin, developed by biotechnology company...
-
Uncategorized4 months agoGlobal collaboration aims to create safer cancer therapeutics
An international collaboration is set to evaluate chemotherapeutic toxicity in human organoids, aiming to generate safer and more effective cancer therapeutics. iXCells Biotechnologies, a provider of...
-
Uncategorized4 months agoDDW Highlights: 26 March 2026
The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates the key stories of the previous week to keep...
-
Uncategorized4 months agoObesity could be treated without suppressing appetite
Obesity could be treated in other ways than using drugs suppressing appetite, a study reveals. Researchers identified how brown fat cells, which are linked to weight loss, communicate...
Novo’s late-stage IL-6 stumble shakes inflammation space
